8ZB6 | pdb_00008zb6

Yeast-expressed polio type 2 stabilized virus-like particles


Experimental Data Snapshot

  • Method: ELECTRON MICROSCOPY
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

wwPDB Validation   3D Report Full Report


This is version 1.2 of the entry. See complete history


Literature

Vaccine Potency and Structure of Yeast-Produced Polio Type 2 Stabilized Virus-like Particles.

Hong, Q.Wang, S.Wang, X.Han, W.Chen, T.Liu, Y.Cheng, F.Qin, S.Zhao, S.Liu, Q.Cong, Y.Huang, Z.

(2024) Vaccines (Basel) 12

  • DOI: https://doi.org/10.3390/vaccines12091077
  • Primary Citation of Related Structures:  
    8ZB6, 8ZH6

  • PubMed Abstract: 

    Poliovirus (PV) is on the brink of eradication due to global vaccination programs utilizing live-attenuated oral and inactivated polio vaccines. Recombinant PV virus-like particles (VLPs) are emerging as a safe next-generation vaccine candidate for the impending polio-free era. In this study, we investigate the production, antigenicity, thermostability, immunogenicity, and structures of VLPs derived from PV serotype 2 (PV2) wildtype strain and thermally stabilized mutant (wtVLP and sVLP, respectively). Both PV2 wtVLP and sVLP are efficiently produced in Pichia pastoris yeast. The PV2 sVLP displays higher levels of D-antigen and significantly enhanced thermostability than the wtVLP. Unlike the wtVLP, the sVLP elicits neutralizing antibodies in mice at levels comparable to those induced by inactivated polio vaccine. The addition of an aluminum hydroxide adjuvant to sVLP results in faster induction and a higher magnitude of neutralizing antibodies. Furthermore, our cryo-EM structural study of both sVLP and wtVLP reveals a native conformation for the sVLP and a non-native expanded conformation for the wtVLP. Our work not only validates the yeast-produced PV2 sVLP as a promising vaccine candidate with high production potential but also sheds light on the structural mechanisms that underpin the assembly and immunogenicity of the PV2 sVLP. These findings may expedite the development of sVLP-based PV vaccines.


  • Organizational Affiliation
    • Key Laboratory of RNA Innovation, Science and Engineering, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China.

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
VP1301Poliovirus 2Mutation(s): 0 
EC: 3.4.22.29 (PDB Primary Data), 3.6.1.15 (PDB Primary Data), 3.4.22.28 (PDB Primary Data), 2.7.7.48 (PDB Primary Data)
UniProt
Find proteins for P06210 (Poliovirus type 2 (strain Lansing))
Explore P06210 
Go to UniProtKB:  P06210
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP06210
Sequence Annotations
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 2
MoleculeChains Sequence LengthOrganismDetailsImage
VP3B [auth C]238Poliovirus 2Mutation(s): 0 
UniProt
Find proteins for P06210 (Poliovirus type 2 (strain Lansing))
Explore P06210 
Go to UniProtKB:  P06210
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP06210
Sequence Annotations
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 3
MoleculeChains Sequence LengthOrganismDetailsImage
VP2C [auth B]271Poliovirus 2Mutation(s): 0 
EC: 3.4.22.29 (PDB Primary Data), 3.6.1.15 (PDB Primary Data), 3.4.22.28 (PDB Primary Data), 2.7.7.48 (PDB Primary Data)
UniProt
Find proteins for P06210 (Poliovirus type 2 (strain Lansing))
Explore P06210 
Go to UniProtKB:  P06210
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP06210
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Experimental Data & Validation

Experimental Data

  • Method: ELECTRON MICROSCOPY
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Resolution: 3.10 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 
EM Software:
TaskSoftware PackageVersion
MODEL REFINEMENTPHENIX

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Chinese Academy of SciencesChina--

Revision History  (Full details and data files)

  • Version 1.0: 2024-09-18
    Type: Initial release
  • Version 1.1: 2024-12-25
    Changes: Data collection, Database references, Structure summary
  • Version 1.2: 2025-07-23
    Changes: Data collection